68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer

Recruiting now

Conditions studied: BREAST CANCER, PET/CT

In brief

The goal of this observational study is to learn whether 68Ga-FAPI PET/CT may be used as a new effective methods for evaluating axillary lymph node efficacy after neoadjuvant treatment for breast cancer. The main question it aims to answer is: Could 68Ga-FAPI PET/CT effectively evaluate axillary lymph node after neoadjuvant treatment for breast cancer? Participants will have a 68Ga-FAPI PET/CT test between last neoadjuvant therapy and surgery.

Key facts

Study ID

NCT06559371

Run by

Kunwei Shen

People needed

150

Starts

2024-08-30

Expected to finish

2026-06-30

Last updated by the study team

2025-12-29

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female patients aged 18 and above
• ECOG score 0-2 points
• Pathological confirmation of malignant breast tumor
• Clinical axillary lymph node positivity (cN+)
• Completed at least 3 courses of neoadjuvant therapy and subjected to undergo surgical treatment
• Informed consent form signed

You may not qualify if…

• Distant metastasis
• Unable to complete the proposed neoadjuvant therapy plan
• Pregnancy

Where it is running

• Shanghai Jiao Tong University School of Medicine, Ruijin Hospital — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.